ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselVersameb AG
Versameb AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Versameb AG discovers and develops RNA-based therapeutics designed to regulate protein expression. Its pipeline includes drug candidates for conditions including stress urinary incontinence and solid tumors.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
✓ Offered7
RNA therapeutics
RNA-based therapeutics for targeted up- or downregulation of proteins, with applications in immunological disorders, oncology and myology.
VERSagile research and development platform
VERSagile platform for nucleotide therapies with the pillars Protein Secretion and Multi-protein target, for developing new molecules and therapeutic concepts.
Drug development for stress urinary incontinence
Development of a lead molecule in an advanced preclinical phase for the treatment of stress urinary incontinence, focusing on functional recovery and tissue regeneration.
Drug development for solid tumors
Development of RNA drug candidates to modulate the tumor microenvironment in solid tumors by simultaneously upregulating and suppressing multiple targets.
Drug development for immunological disorders
Development of RNA-based molecules to regulate the immune response in areas where immunomodulatory treatment approaches are needed.
Drug development in myology
Development of RNA therapeutic molecules for myology indications with regenerative and protein-regulating approaches.
Partnerships for RNA therapies
Partnerships to jointly use the VERSagile platform with selected partners who want to apply optimized mRNA to medical need scenarios.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Versameb AG

Trust & reputation

ranQ Trust Score of Versameb AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of November 2026

Without public customer reviews the score stays capped.

Versameb AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Versameb AG scores 82.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Versameb AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Versameb AG scores 23.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.37.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

Versameb AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

January 11, 2021Media
New leaders on the executive floor
startupticker.ch

Knowledge

No knowledge articles yet

Once Versameb AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Versameb AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Versameb AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Versameb AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstr. 60C
4057 Basel
Opening hours
Mon
09:00 - 18:00
Tue
09:00 - 18:00
Wed
09:00 - 18:00
Thu
09:00 - 18:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-404.818.740
Founded
2017 · 9 years
Last commercial register change
October 9, 2025
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    ST
    Skyhawk Therapeutics Europe GmbH
    Basel
    CT
    Cimeio Therapeutics AG
    Basel
    MR
    Monte Rosa Therapeutics AG
    Basel
    MB
    MabTree Biologics AG
    Basel
    BA
    BioVersys AG
    Basel
    RG
    RXcel GmbH
    Basel
    CD
    CORETAG Diagnostics AG
    Basel
    YA
    Ymmunobio AG
    Riehen